NM_000157.4:c.1534A>T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_StrongPP5
The NM_000157.4(GBA1):c.1534A>T(p.Lys512*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000157.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBA1 | NM_000157.4 | c.1534A>T | p.Lys512* | stop_gained | Exon 11 of 11 | ENST00000368373.8 | NP_000148.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 16
GnomAD4 exome Cov.: 14
GnomAD4 genome Cov.: 16
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
- -
not specified Uncertain:1
Variant summary: GBA c.1534A>T (p.Lys512X) results in a premature termination codon, predicted to cause a truncation of the encoded protein. The variant was absent in 238222 control chromosomes (gnomAD). To our knowledge, no occurrence of c.1534A>T in individuals affected with Gaucher Disease and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at